Stock Track | United Therapeutics Soars 5.59% Pre-Market on $1 Billion Share Buyback Announcement

Stock Track

Aug 01, 2025

United Therapeutics Corporation (UTHR) saw its stock surge 5.59% in pre-market trading, following the company's announcement of a substantial $1 billion accelerated share repurchase program. This move signals strong confidence from the company's management in its near-term prospects and financial stability.

The pharmaceutical firm revealed that it has entered into two accelerated share repurchase agreements with Citibank, N.A. to execute the program. This strategic decision underscores United Therapeutics' commitment to enhancing shareholder value and optimizing its capital structure.

Investors have responded positively to this news, as share repurchase programs typically indicate that a company believes its stock is undervalued. Moreover, such programs can lead to improved earnings per share by reducing the number of outstanding shares. The pre-market rally suggests that the market views this as a bullish signal for United Therapeutics' future performance and financial health.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1182421891"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182421891\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182421891?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-01 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182421891","market":"nz","top_or_hot":-1,"title":"Stock Track | United Therapeutics Soars 5.59% Pre-Market on $1 Billion Share Buyback Announcement","media":"Stock Track","content":"<p>United Therapeutics Corporation (UTHR) saw its stock surge 5.59% in pre-market trading, following the company's announcement of a substantial $1 billion accelerated share repurchase program. This move signals strong confidence from the company's management in its near-term prospects and financial stability.</p>\n\n<p>The pharmaceutical firm revealed that it has entered into two accelerated share repurchase agreements with Citibank, N.A. to execute the program. This strategic decision underscores United Therapeutics' commitment to enhancing shareholder value and optimizing its capital structure.</p>\n\n<p>Investors have responded positively to this news, as share repurchase programs typically indicate that a company believes its stock is undervalued. Moreover, such programs can lead to improved earnings per share by reducing the number of outstanding shares. The pre-market rally suggests that the market views this as a bullish signal for United Therapeutics' future performance and financial health.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | United Therapeutics Soars 5.59% Pre-Market on $1 Billion Share Buyback Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | United Therapeutics Soars 5.59% Pre-Market on $1 Billion Share Buyback Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-01 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>United Therapeutics Corporation (UTHR) saw its stock surge 5.59% in pre-market trading, following the company's announcement of a substantial $1 billion accelerated share repurchase program. This move signals strong confidence from the company's management in its near-term prospects and financial stability.</p>\n\n<p>The pharmaceutical firm revealed that it has entered into two accelerated share repurchase agreements with Citibank, N.A. to execute the program. This strategic decision underscores United Therapeutics' commitment to enhancing shareholder value and optimizing its capital structure.</p>\n\n<p>Investors have responded positively to this news, as share repurchase programs typically indicate that a company believes its stock is undervalued. Moreover, such programs can lead to improved earnings per share by reducing the number of outstanding shares. The pre-market rally suggests that the market views this as a bullish signal for United Therapeutics' future performance and financial health.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UTHR","symbol_name":"美国联合医疗","start_time":0,"source_url":"","article_id":"1182421891","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182421891","pubTimestamp":1754046756,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"United Therapeutics Corporation (UTHR) saw its stock surge 5.59% in pre-market trading, following the company's announcement of a substantial $1 billion accelerated share repurchase program. This...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UTHR":"美国联合医疗"},"translate_title":"个股追踪|United Therapeutics宣布10亿美元股票回购盘前大涨5.59%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UTHR":1},"content_text":"United Therapeutics Corporation (UTHR) saw its stock surge 5.59% in pre-market trading, following the company's announcement of a substantial $1 billion accelerated share repurchase program. This move signals strong confidence from the company's management in its near-term prospects and financial stability.\nThe pharmaceutical firm revealed that it has entered into two accelerated share repurchase agreements with Citibank, N.A. to execute the program. This strategic decision underscores United Therapeutics' commitment to enhancing shareholder value and optimizing its capital structure.\nInvestors have responded positively to this news, as share repurchase programs typically indicate that a company believes its stock is undervalued. Moreover, such programs can lead to improved earnings per share by reducing the number of outstanding shares. The pre-market rally suggests that the market views this as a bullish signal for United Therapeutics' future performance and financial health.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}